Improved Humoral Immunity and Protection Against Influenza Virus Infection With a 3D Porous Biomaterial Vaccine

    Hiromi Miwa, Olivia Q Antao, Kindra M. Kelly-Scumpia, Sevana Baghdasarian, Daniel P. Mayer, Lily Shang, Gina M. Sanchez, Maani M. Archang, Philip O. Scumpia, Jason S. Weinstein, Dino Di Carlo
    Image
    Studysummary This study reported that an injectable hydrogel microparticle vaccine platform enhanced antibody responses and protection against influenza in mice, outperforming the traditional adjuvant aluminum hydroxide. Our plain-language summary of this paper — not a Tressless recommendation.
    The study developed an injectable immunization platform using a slurry of antigen-loaded hydrogel microparticles that form a porous scaffold for antigen uptake by immune cells. This platform was found to stimulate a strong cellular humoral immune response, with increased CD4+ T follicular helper (Tfh) cells and prolonged germinal center (GC) B cells, comparable to the commonly used adjuvant, aluminum hydroxide (Alum). By increasing the weight fraction of polymer material, the researchers enhanced material stiffness and further increased antigen-specific antibody titers, superior to Alum. When mice were vaccinated with inactivated influenza virus loaded into this more highly crosslinked formulation, it elicited a strong antibody response and provided better protection against a high dose viral challenge than Alum. This suggests that by tuning physical and chemical properties alone, we can enhance adjuvanticity and promote humoral immunity and protection against a pathogen.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results